They booked roughly 544,000 revenue from the Biotech deal in that quarter which to a certain extent is an advance payment. I don't think Biotech actually sold that many veneers in that quarter because the deal was only announced on Feb 18th.
If Biotech go through the pre-paid veneer inventory slowly, then this or next quarter will show less revenue from Biotech in the total revenue line.
Revenue from the franchises was about 350,000 (I am unsure as to the makeup of the other portion of revenue)
I think he has to show the core business can be consistently cash flow positive and grow a bit - which allows China to do its thing to boost the stock price.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM